“…Further reviews have highlighted the wide array of therapeutics isolated from endophytes that mimic therapeutic plantderived secondary metabolites, e.g. antioxidants (Lapachol, Cajanin stillbene acid, Resveratrol, Rutin, Phillyrin), antihypercholesteromics (Rosuvastatin, Piperin, Chartarlactams, Phenlspirodrimanes, Lovastatin), antidiabetics (2,6-di-tert-butyl-p-cresol, Berberine, Cajanol, Aspergillusol A, Rohitukine, Helvolic acid), and further compounds identical to plant-derived anticancer compounds (Taxol, Hypericin, Vincristine, Vinblastine, Camptothecin, Podophyllotoxin, Kaempferol, Azadirachtin, Rohitukine) [189][190][191] possibly as an ecological survival strategy [168]. In a few cases, research shows endophytic compounds to be exceedingly rare, yet especially useful medically, such as the unique mellein compounds of Aspergillus flocculus (Tawfike et al, 2019).…”